Cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as MS, and rely on results of cell-based assays. https://t.co/1MZd0WEzPL @ECTRIMS@ACTRIMS#MSMilan2023